Oup Management Co., LLC Biotechnology

Oup Management Co., LLC

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
CNTA Centessa Pharmaceuticals PLC	$1.51B	$19 Million 42.75% of portfolio	2,937,615	Q1 2022 Added 25.44%
AVTE Aerovate Therapeutics, Inc.	$61.9M	$8.19 Million 18.43% of portfolio	603,762	Q4 2021 New
CYT Cyteir Therapeutics, Inc.	$107M	$6.99 Million 15.71% of portfolio	2,459,572	Q4 2022 Reduced 0.4%
PMVP Pmv Pharmaceuticals, Inc.	$73.5M	$6.07 Million 13.66% of portfolio	989,232	Q4 2021 New
GRPH Graphite Bio, Inc.	$0	$1.01 Million 2.26% of portfolio	406,308	Q4 2021 New
SELB Selecta Biosciences Inc	$128M	$914,000 2.06% of portfolio	862,543	Q4 2021 New
VOR Vor Biopharma Inc.	$32.7M	$794,000 1.79% of portfolio	374,714	Q4 2021 New
EFTR E Ffector Therapeutics, Inc.	$0	$615,000 1.38% of portfolio	1,025,697	Q4 2021 New
DTIL Precision Biosciences Inc	$842M	$382,000 0.86% of portfolio	1,123,913	Q4 2021 New
SPRO Spero Therapeutics, Inc.	$41.4M	$301,000 0.68% of portfolio	249,070	Q4 2021 New
IKNA Ikena Oncology, Inc.	$61.3M	$116,000 0.26% of portfolio	26,833	Q3 2023 New
FIXX Homology Medicines, Inc.	$0	$74,000 0.17% of portfolio	64,000	Q4 2021 New

Get notified when there are updates to the investment portfolio of Oup Management Co., LLC, based on Form 13F filings with the SEC.

Stay updated on Oup Management Co., LLC with notifications on news.